Hemodialysis International 2015; 19:499–508
Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients Gaurav AGARWAL,1 Karina VASQUEZ,1 Neena PENAGALURU,1 Jonathan GELFOND,2 Wajeh Y. QUNIBI1 1
Nephrology Division, Department of Medicine, 2Department of Epidemiology and Biostatistics, The University of Texas Health Science Center San Antonio, San Antonio, Texas, USA
Abstract Vitamin D deficiency or insufficiency is highly prevalent among patients with chronic kidney disease (CKD). This study aims to determine the relationship between vitamin D and frequency of vascular access dysfunction (VAD) in hemodialysis (HD) patients. We reviewed medical records of all HD patients who had serum 25-hydroxyvitamin D (25OHD) levels at 4 outpatient dialysis facilities between January 2011 and January 2012. Patients were included if they were ≥18 years of age, had been on maintenance dialysis for ≥3 months, and had native arteriovenous fistula or synthetic polytetrafluoroethylene grafts for dialysis access. Patients with catheters were excluded. 25-Hydroxyvitamin D levels
Treatment of vitamin D deficiency/insufficiency with ergocalciferol is associated with reduced vascular access dysfunction in chronic hemodialysis patients Gaurav AGARWAL,1 Karina VASQUEZ,1 Neena PENAGALURU,1 Jonathan GELFOND,2 Wajeh Y. QUNIBI1 1
Nephrology Division, Department of Medicine, 2Department of Epidemiology and Biostatistics, The University of Texas Health Science Center San Antonio, San Antonio, Texas, USA
Abstract Vitamin D deficiency or insufficiency is highly prevalent among patients with chronic kidney disease (CKD). This study aims to determine the relationship between vitamin D and frequency of vascular access dysfunction (VAD) in hemodialysis (HD) patients. We reviewed medical records of all HD patients who had serum 25-hydroxyvitamin D (25OHD) levels at 4 outpatient dialysis facilities between January 2011 and January 2012. Patients were included if they were ≥18 years of age, had been on maintenance dialysis for ≥3 months, and had native arteriovenous fistula or synthetic polytetrafluoroethylene grafts for dialysis access. Patients with catheters were excluded. 25-Hydroxyvitamin D levels
